Skip to content

Insider · CIK 0001601831

Timothy T. Richards

director

Files at CLPT (ClearPoint Neuro, Inc.). First filing Jun 12, 2025, latest Jun 2, 2026.

In brief

Timothy T. Richards files SEC Form 4 as director at CLPT (ClearPoint Neuro, Inc.). Since Jun 12, 2025, Timothy T. Richards has reported 0 open-market buys worth $0 and 2 open-market sells worth $199k, the latest filed on Jun 2, 2026.

A track record needs three past buys with six months of prices behind them; Timothy T. Richards has 0, so none is measured yet.

The newest scored trade: sold $66k of CLPT on Jun 1, 2026, filed Jun 2, 2026, scored 38 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $66k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $199k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CLPT: ClearPoint Neuro, Inc.

CLPTOct 12, 2026 · close 10.20

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
38Weak
CLPTsell 3
ClearPoint Neuro, Inc.
$66k
5,415 shares
-6%+46% from low-57% from high
46Moderate
CLPTsell 3
ClearPoint Neuro, Inc.
$133k
10,000 shares
-11%+26% from low-30% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 1, 2026 CLPT
ClearPoint Neuro, Inc.
5,145
0.02% of outstanding
$63kJun 1, 2026none
Jun 10, 2025 CLPT
ClearPoint Neuro, Inc.
10,000
0.04% of outstanding
$133kJun 10, 2025none

Transactions

Every row this insider has filed, 20 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 1, 2026CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+319$12.21$3,89587,86312 d ago
Jul 1, 2026CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+222$17.84$3,96087,544Jul 6, 2026
Jun 4, 2026CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+500$10.00$5,00087,698Jun 8, 2026
Jun 4, 2026CLPT
ClearPoint Neuro, Inc.
FTax withholding
Common Stock
-376$13.30$5,00187,322Jun 8, 2026
Jun 4, 2026CLPT
ClearPoint Neuro, Inc.
MOption exercise
Stock Options (right to buy)derivative
-500$10.00$5,0000Jun 8, 2026
Jun 1, 2026CLPT
ClearPoint Neuro, Inc.
SOpen-market sale
Common Stock
-5,415$12.17$66k87,198Jun 2, 2026
May 21, 2026CLPT
ClearPoint Neuro, Inc.
AGrant or award
Restricted Stock Unitsderivative
+12,820$0.00$012,820May 26, 2026
May 19, 2026CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+12,417--92,613May 21, 2026
May 19, 2026CLPT
ClearPoint Neuro, Inc.
MOption exercise
Restricted Stock Unitsderivative
-12,417--0May 21, 2026
Apr 1, 2026CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+442$9.10$4,02280,196Apr 2, 2026
Jan 2, 2026CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+884$13.68$12k79,754Jan 5, 2026
Oct 1, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+555$21.79$12k78,870Oct 2, 2025
Jul 1, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+934$11.94$11k78,315Jul 2, 2025
Jun 10, 2025CLPT
ClearPoint Neuro, Inc.
SOpen-market sale
Common Stock
-10,000$13.28$133k77,381Jun 12, 2025
May 22, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Restricted Stock Unitsderivative
+12,417$0.00$012,417May 23, 2025
May 16, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Common Stock
+21,093--87,381May 19, 2025
May 16, 2025CLPT
ClearPoint Neuro, Inc.
MOption exercise
Restricted Stock Unitsderivative
-21,093--0May 19, 2025
Apr 1, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+938$11.89$11k66,288Apr 2, 2025
Jan 2, 2025CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+725$15.38$11k65,350Jan 3, 2025
Jan 2, 2024CLPT
ClearPoint Neuro, Inc.
AGrant or award
Common Stock
+1,643$6.79$11k42,768Jan 3, 2024

Questions about Timothy T. Richards

Answered from the filings on this page, as of the latest one.

Is Timothy T. Richards buying or selling?

In the last 12 months Timothy T. Richards reported 0 open-market buys worth $0 and 1 open-market sell worth $66k on SEC Form 4; the latest was sold $66k of CLPT on Jun 1, 2026. Grants, option exercises and tax withholding are not counted.

How did Timothy T. Richards's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy T. Richards has 0.

Where does Timothy T. Richards file Form 4?

Timothy T. Richards has filed Form 4 at CLPT (ClearPoint Neuro, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Timothy T. Richards: insider trades and track record | InsiderTell